Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins

Umberto Basile, Cecilia Napodano, Krizia Pocino, Francesca Gulli, Stefano Angelo Santini, Laura Todi, Mariapaola Marino, Gian Ludovico Rapaccini

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Clinical spectrum of hepatitis C virus (HCV)-related cryoglobulinemia varies from an asymptomatic presentation to severe vasculitis and lymphoma. A recent study in HCV-negative patients suggests that low cryoglobulins (CGs) levels are responsible for severe renal and neurological complications. The aim of this study was to identify a panel of serological biomarkers associated with low levels of CGs in HCV-positive patients. We studied a population of 79 untreated patients with chronic HCV infection: 13 naïve patients without CGs; 28 patients with asymptomatic mixed cryoglobulinemia (MC) and low levels of CGs (16/28 with polyclonal type III and 12/28 with microheterogeneous type III CGs); 38 patients with symptomatic MC and high levels of type II CGs. Serum samples were collected and examined for rheumatoid factor (RF) IgG and IgM, free light chains (FLCs) and C3 and C4 complement components. We found that RF-IgG and IgM, free k chains and k+λ were increased while C4 component was reduced, both in symptomatic and asymptomatic patients. Our results suggest that, even in absence of MC symptoms, the low levels of CGs may represent a trigger of activation for immune system in course of HCV infection. The identification of a correlated biomarkers panel could improve the clinical management of these patients and pave the way for target treatment strategies.

Original languageEnglish
JournalBioFactors
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Cryoglobulins
Viruses
Hepacivirus
Cryoglobulinemia
Rheumatoid Factor
Biomarkers
Virus Diseases
Immunoglobulin M
Immunoglobulin G
Complement C4
Immune system
Chronic Hepatitis C
Vasculitis
Chemical activation
Immune System
Lymphoma
Kidney
Light

Keywords

  • biomarkers
  • Cryoglobulins
  • free light chains
  • HCV
  • RF-IgG/IgM

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Clinical Biochemistry

Cite this

Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins. / Basile, Umberto; Napodano, Cecilia; Pocino, Krizia; Gulli, Francesca; Santini, Stefano Angelo; Todi, Laura; Marino, Mariapaola; Rapaccini, Gian Ludovico.

In: BioFactors, 01.01.2018.

Research output: Contribution to journalArticle

Basile, Umberto ; Napodano, Cecilia ; Pocino, Krizia ; Gulli, Francesca ; Santini, Stefano Angelo ; Todi, Laura ; Marino, Mariapaola ; Rapaccini, Gian Ludovico. / Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins. In: BioFactors. 2018.
@article{35f2e010986a40a9ac01baa58b4b9986,
title = "Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins",
abstract = "Clinical spectrum of hepatitis C virus (HCV)-related cryoglobulinemia varies from an asymptomatic presentation to severe vasculitis and lymphoma. A recent study in HCV-negative patients suggests that low cryoglobulins (CGs) levels are responsible for severe renal and neurological complications. The aim of this study was to identify a panel of serological biomarkers associated with low levels of CGs in HCV-positive patients. We studied a population of 79 untreated patients with chronic HCV infection: 13 na{\"i}ve patients without CGs; 28 patients with asymptomatic mixed cryoglobulinemia (MC) and low levels of CGs (16/28 with polyclonal type III and 12/28 with microheterogeneous type III CGs); 38 patients with symptomatic MC and high levels of type II CGs. Serum samples were collected and examined for rheumatoid factor (RF) IgG and IgM, free light chains (FLCs) and C3 and C4 complement components. We found that RF-IgG and IgM, free k chains and k+λ were increased while C4 component was reduced, both in symptomatic and asymptomatic patients. Our results suggest that, even in absence of MC symptoms, the low levels of CGs may represent a trigger of activation for immune system in course of HCV infection. The identification of a correlated biomarkers panel could improve the clinical management of these patients and pave the way for target treatment strategies.",
keywords = "biomarkers, Cryoglobulins, free light chains, HCV, RF-IgG/IgM",
author = "Umberto Basile and Cecilia Napodano and Krizia Pocino and Francesca Gulli and Santini, {Stefano Angelo} and Laura Todi and Mariapaola Marino and Rapaccini, {Gian Ludovico}",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/biof.1485",
language = "English",
journal = "BioFactors",
issn = "0951-6433",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins

AU - Basile, Umberto

AU - Napodano, Cecilia

AU - Pocino, Krizia

AU - Gulli, Francesca

AU - Santini, Stefano Angelo

AU - Todi, Laura

AU - Marino, Mariapaola

AU - Rapaccini, Gian Ludovico

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Clinical spectrum of hepatitis C virus (HCV)-related cryoglobulinemia varies from an asymptomatic presentation to severe vasculitis and lymphoma. A recent study in HCV-negative patients suggests that low cryoglobulins (CGs) levels are responsible for severe renal and neurological complications. The aim of this study was to identify a panel of serological biomarkers associated with low levels of CGs in HCV-positive patients. We studied a population of 79 untreated patients with chronic HCV infection: 13 naïve patients without CGs; 28 patients with asymptomatic mixed cryoglobulinemia (MC) and low levels of CGs (16/28 with polyclonal type III and 12/28 with microheterogeneous type III CGs); 38 patients with symptomatic MC and high levels of type II CGs. Serum samples were collected and examined for rheumatoid factor (RF) IgG and IgM, free light chains (FLCs) and C3 and C4 complement components. We found that RF-IgG and IgM, free k chains and k+λ were increased while C4 component was reduced, both in symptomatic and asymptomatic patients. Our results suggest that, even in absence of MC symptoms, the low levels of CGs may represent a trigger of activation for immune system in course of HCV infection. The identification of a correlated biomarkers panel could improve the clinical management of these patients and pave the way for target treatment strategies.

AB - Clinical spectrum of hepatitis C virus (HCV)-related cryoglobulinemia varies from an asymptomatic presentation to severe vasculitis and lymphoma. A recent study in HCV-negative patients suggests that low cryoglobulins (CGs) levels are responsible for severe renal and neurological complications. The aim of this study was to identify a panel of serological biomarkers associated with low levels of CGs in HCV-positive patients. We studied a population of 79 untreated patients with chronic HCV infection: 13 naïve patients without CGs; 28 patients with asymptomatic mixed cryoglobulinemia (MC) and low levels of CGs (16/28 with polyclonal type III and 12/28 with microheterogeneous type III CGs); 38 patients with symptomatic MC and high levels of type II CGs. Serum samples were collected and examined for rheumatoid factor (RF) IgG and IgM, free light chains (FLCs) and C3 and C4 complement components. We found that RF-IgG and IgM, free k chains and k+λ were increased while C4 component was reduced, both in symptomatic and asymptomatic patients. Our results suggest that, even in absence of MC symptoms, the low levels of CGs may represent a trigger of activation for immune system in course of HCV infection. The identification of a correlated biomarkers panel could improve the clinical management of these patients and pave the way for target treatment strategies.

KW - biomarkers

KW - Cryoglobulins

KW - free light chains

KW - HCV

KW - RF-IgG/IgM

UR - http://www.scopus.com/inward/record.url?scp=85058687637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058687637&partnerID=8YFLogxK

U2 - 10.1002/biof.1485

DO - 10.1002/biof.1485

M3 - Article

AN - SCOPUS:85058687637

JO - BioFactors

JF - BioFactors

SN - 0951-6433

ER -